- Home
- VEON vs DAWN Comparison
VEON vs DAWN Comparison
Compare VEON & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VEON
- DAWN
- Stock Information
- Founded
- VEON 1992
- DAWN 2018
- Country
- VEON United Arab Emirates
- DAWN United States
- Employees
- VEON N/A
- DAWN N/A
- Industry
- VEON Telecommunications Equipment
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- VEON Telecommunications
- DAWN Health Care
- Exchange
- VEON Nasdaq
- DAWN Nasdaq
- Market Cap
- VEON 2.7B
- DAWN 658.9M
- IPO Year
- VEON 1996
- DAWN 2021
- Fundamental
- Price
- VEON $49.39
- DAWN $7.02
- Analyst Decision
- VEON Strong Buy
- DAWN Strong Buy
- Analyst Count
- VEON 1
- DAWN 7
- Target Price
- VEON $60.00
- DAWN $31.57
- AVG Volume (30 Days)
- VEON 316.2K
- DAWN 1.3M
- Earning Date
- VEON 08-07-2025
- DAWN 07-29-2025
- Dividend Yield
- VEON N/A
- DAWN N/A
- EPS Growth
- VEON N/A
- DAWN N/A
- EPS
- VEON 6.56
- DAWN N/A
- Revenue
- VEON $4,088,000,000.00
- DAWN $161,922,000.00
- Revenue This Year
- VEON $6.27
- DAWN $17.98
- Revenue Next Year
- VEON $6.79
- DAWN $49.50
- P/E Ratio
- VEON $6.94
- DAWN N/A
- Revenue Growth
- VEON 8.84
- DAWN N/A
- 52 Week Low
- VEON $25.83
- DAWN $6.08
- 52 Week High
- VEON $59.68
- DAWN $16.76
- Technical
- Relative Strength Index (RSI)
- VEON 60.22
- DAWN 58.34
- Support Level
- VEON $42.54
- DAWN $6.52
- Resistance Level
- VEON $46.81
- DAWN $7.24
- Average True Range (ATR)
- VEON 2.75
- DAWN 0.26
- MACD
- VEON 0.83
- DAWN 0.07
- Stochastic Oscillator
- VEON 52.27
- DAWN 78.37
About VEON VEON Ltd. ADS
VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.